--- title: "Weekly Recap | Astera Labs -11.39%, most brokers rate it buy" type: "News" locale: "en" url: "https://longbridge.com/en/news/296666834.md" description: "Astera Labs fell 11.39% this week to close at $284.97, underperforming the S&P 500 by roughly 9.96 percentage points as the benchmark shed 1.43%. Monday (17 Aug) opened at $344.95 and hit an intra-week high of $354 before reversing sharply to end at $320.17. Tuesday gapped lower to $304, briefly bounced to $311.95, then settled at $303.44. Selling accelerated on Wednesday, with the stock touching a low of $278.175 before closing at $289.02." datetime: "2026-08-22T04:31:12.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/296666834.md) - [en](https://longbridge.com/en/news/296666834.md) - [zh-HK](https://longbridge.com/zh-HK/news/296666834.md) generator: "portal-rs" --- # Weekly Recap | Astera Labs -11.39%, most brokers rate it buy ## The Week Astera Labs fell 11.39% this week to close at $284.97, underperforming the S&P 500 by roughly 9.96 percentage points as the benchmark shed 1.43%. Monday (17 Aug) opened at $344.95 and hit an intra-week high of $354 before reversing sharply to end at $320.17. Tuesday gapped lower to $304, briefly bounced to $311.95, then settled at $303.44. Selling accelerated on Wednesday, with the stock touching a low of $278.175 before closing at $289.02. Thursday and Friday saw range-bound trading between $277.30 and $296.88, ultimately finishing the week at $284.97. Weekly amplitude reached 22.24%, while average daily volume of about 4.1m shares ran roughly 19% below the 60-day median. ## Key Events The week began on a positive note as Northland Capital upgraded Astera Labs to ‘outperform’ with a $350 target, citing expectations of a prolonged AI spending cycle. The stock surged over 3% in pre-market and more than 7% at the open on Monday, briefly touching the week’s high of $354. The rally proved short-lived: selling pressure emerged on Tuesday, sending shares down over 5% in pre-market, with the decline extending through the regular session. Midweek, reports that major storage players were scaling back CXL controller plans weighed on sentiment, driving a further 7% drop on Wednesday. On Thursday, news broke that Astera insiders had recently sold shares worth over $64m, adding to the cautious tone. Flow data painted a mixed picture: Amazon disclosed a purchase of roughly 278,000 shares, and Valliance Asset Management took a $162.85m position just after the week ended, while NewEdge Advisors trimmed its stake by 5,679 shares. ## Analyst Ratings Of the 26 brokers covering Astera Labs, 12 rate it ‘buy’, 7 rate it ‘over’, and 7 rate it ‘hold’ — none has an ‘under’ or ‘sell’ rating. The consensus recommendation stands at ‘buy’, with a consensus target of $389.95, implying about 36.8% upside from the week’s close. Individual targets range from $190 to $500, reflecting a wide spread of opinion. Among 76 semiconductor companies tracked, Astera Labs ranks 15th by analyst rating. ## The Week Ahead Next week brings a batch of US macro data on Tuesday, 25 Aug: FHFA house price indices, the Case-Shiller 20-city index, the Richmond Fed composite index, consumer confidence, and new home sales figures. These releases will offer a read on the broader economy and consumer spending trends. For Astera Labs, the key watchpoints are whether the CXL controller pullback story gains further traction and whether sentiment stabilises after the insider selling headlines. ## In Short Astera Labs endured a sharp sell-off this week despite an analyst upgrade, with a 22% intra-week swing underscoring the market’s sensitivity to AI-linked high-multiple names. The broker consensus skews positive and the consensus target sits well above the spot price, yet the wide range of analyst targets reveals a lack of firm conviction on the pace of medium-term growth. The latest session’s flow data showed retail money as a net buyer while mid-tier funds turned net sellers — a split picture that leaves near-term direction unresolved. The focus now shifts to any follow-through on the CXL narrative and whether AI capex expectations can regroup to draw buyers back. *This article is generated by LongbridgeAI from market data, for information only and not investment advice.* ### Related Stocks - [ALAB.US](https://longbridge.com/en/quote/ALAB.US.md) - [LABX.US](https://longbridge.com/en/quote/LABX.US.md) ## Related News & Research - [Astera Labs (NASDAQ:ALAB) Shares Gap Down Following Insider Selling](https://longbridge.com/en/news/291948131.md) - [Astera Labs Analysts Boost Their Forecasts Following Better-Than-Expected Q2 Earnings](https://longbridge.com/en/news/294963676.md) - [Astera Labs (ALAB) Posts Record Earnings, Is The Stock Now Too Expensive?](https://longbridge.com/en/news/295304913.md) - [Astera Labs' Post-Earnings Pullback May Be Last Chance to Buy Below $360](https://longbridge.com/en/news/295127470.md) - [Stefan Dyckerhoff Sells 8,994 Shares of Astera Labs (NASDAQ:ALAB) Stock](https://longbridge.com/en/news/295451755.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**